Orange lines on a white background

Innovate To Create

Zymeron is a research-based biotechnology company that discover, develop and commercialize healthcare innovations with step-change performance.

Our Technologies

Our innovators developed drug delivery and formulation technologies to bridge gaps in pharmaceutical sciences that are manifested by multiple unmet clinical needs.

Bone Marrow Drug Delivery Platform – Our proprietary peptide drug conjugate (PDC) demonstrated its advantages and benefits in delivering a cytoprotective molecule to protect hematopoietic stem and progenitor cells from chemotherapy or radiation induced myelotoxicity.

Reformulate Poorly Soluble Drugs to Injectables – Converting insoluble or poorly soluble small molecule drugs to highly soluble non-covalent molecular variants is a requirement to repurpose these oral drugs for use as emergency medicine (hemorrhage shock, sepsis).

Dual Biologic-Small Molecule Delivery System – The delivery of biologics and small molecule drugs in one system is achieved through uniquely engineered extracellular vesicles (e.g. exosome) clinically benefiting the management of wound biofilm.

With our partners, we collaboratively develop rapid companion wound diagnostic tests to facilitate patient management at the point of care, and develop a revolutionary AL-aided rapid sterility test in biomanufacturing quality control. These auxiliary products and solutions enhance the commercial values of our primary pharmaceutical technologies.

Our Partners

We have an extended list of partners in academia, industry, government, and non-profit organizations. We work closely with numerous government agencies including the Department of Defense and the Department of Health and Human Services to develop innovative products to meet the nation’s health and defense needs. We commercialize advanced materials and health-related technologies and bring them to market in partnership with commercial entities.